1955 Capital

1955 Capital is a venture capital firm with it's headquarters in Los Altos, CA. It invests in technologies developed in the Americas and Europe that can help solve China's and the developing world's challenges in areas like energy & environment, food safety & supply, health & education, and sustainable manufacturing.

The firm was founded by Andrew Chung, a former general partner at Khosla Ventures, with investing experience in these sectors and exposure to commercializing numerous technologies in China and other regions. The private equity company was founded in 2015 and focuses on the energy and environment, health and education, food safety and supply, emerging technologies, and energy and environment sectors. 1955 Capital has raised a total of $200M in funding. It has 2 companies in its portfolio, and its first investment was made in 2016. The firm has an estimated revenue of less than $1m.

1955 Capital invests in tech from the Americas and Europe to solve the greatest challenges in the developing world, starting with China, in energy, food, health, education. 1955 Capital has made 2 investments. One was on Sep 13, 2017, where they invested $8.5M in Crop Enhancement and the second on Sep 7, 2017, when they invested $11M in Gridtential Energy. 1955 Capital has raised a total of $200M in a single venture fund, 1995 Capital Fund I. This fund was announced on Feb 24, 2016.

With a first close on $200 million completed, 1955 Capital will allow entrepreneurs and innovators gain direct access to these end-markets to accelerate technology commercialization, create jobs, and foster partnerships that will support their long-term growth and development. China, India & other developing countries have survival-driven demands that can accelerate tech commercialization. 1955 Capital can serve as a cultural bridge by assisting management teams in evaluating and potentially entering China, India, and other emerging markets. Identify arbitrage opportunities to leverage gaps across geographies in technology, regulations, capital availability, and culture to maximize both impact and return. The firm means to identify strategic partners in China, India and other developing countries to assist with cross-border execution.

Slow China's growth in heart disease, cancer, and diabetes. Alleviate the increasing healthcare burden from rising wages & aging population .

Deliver safe drinking water to 600 million people in China and India. Decontaminate 25% of China's farmland.

Make manufacturing growth sustainable via the latest advances in 3D printing, robotics, machine vision, networking, IOT, and sensors .

Prevent 2 million annual deaths due to air pollution in China. Reduce the high incidence of chronic asthma in India .